# SURE-01 (NCT05226117)

> Sacituzumab Govitecan, Preceding Radical Cystectomy, in Treating Patients With Muscle-invasive Bladder Cancer

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT05226117
- Phase: PHASE2
- Status: COMPLETED
- Sponsor: IRCCS San Raffaele
- Conditions: Urothelial Carcinoma
- Interventions: Sacituzumab govitecan
- Enrollment: 44
- Primary outcome: Pathological complete response

## Indexed commentary on SURE-01 so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- X threads: 36
- YouTube: 6
- Podcasts: 3
- Bluesky threads: 1

## Order

Deep, $1,950, price fixed at order: https://www.erudio.com/contact?report=sure-01-nct05226117

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT05226117", "email": "<work email>"}; the inbox owner confirms by the emailed link.